Sparo is a digital health company transforming respiratory care.
Empowering patients to quantitatively and proactively manage respiratory diseases Sparo is committed to tackling the rising healthcare burden of chronic respiratory diseases through the development of an award-winning, pocket-sized spirometer for proactive management of asthma, COPD, cystic fibrosis, and other respiratory diseases.
Due to high cost and tedious maintenance, spirometers historically have been relegated to pulmonologists and hospitals; however, our innovative solution can be produced for a fraction of the cost of current spirometers while both increasing durability and maintaining accuracy.
Through seamless integration with mobile devices, our solution bridges the gap between a medical device and consumer tech product, crafting an engaging and meaningful experience for users. Putting this powerful technology in the hands of patients will alter the management of respiratory diseases worldwide.
Their flagship product, Wing is the 1st FDA-cleared, over-the-counter smartphone sensor to measure lung function—empowering people with COPD, asthma, and other conditions to proactively manage their health.
Locations
Industries
Financials
- $3.6m